Luigi Naldini
Luigi Naldini (born 1959 in Turin) is an Italian gene therapist, professor of cell and tissue biology and of gene and cell therapy at Vita-Salute San Raffaele University, and the director of San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Often considered as ''"the father of the lentivirus gene therapy"'', he is globally known as the pioneer of "the development and applications of lentiviral vectors for gene transfer" that allowed the gene therapy treatment of several genetic diseases. He is also a scientific co-founder of three biotech start-up companies, Genenta in Milan and New York, Chroma Medicine in Milan and Boston, Genespire in Milan. He is also the former president of European Society of Gene and Cell Therapy (ESGCT) and an elected member of European Molecular Biology Organization (EMBO). In 2019, he was awarded Louis-Jeantet Prize for Medicine "for taking gene therapy from the bench to the bedside". Provided by Wikipedia
1
Published: [2012]
Superior document: Title is part of eBook package: De Gruyter EDP Sciences Backlist eBook Package 2000-2013
Links: Get full text; Get full text; Cover